BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8245481)

  • 1. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis.
    Makker SP
    J Immunol; 1993 Dec; 151(11):6500-8. PubMed ID: 8245481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
    Kerjaschki D; Miettinen A; Farquhar MG
    J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
    Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
    Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible ligand of serum origin for the kidney autoantigen of Heymann nephritis.
    Kanalas JJ; Makker SP
    J Immunol; 1988 Dec; 141(12):4152-7. PubMed ID: 3264306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
    Kerjaschki D; Farquhar MG
    J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330).
    Kanalas JJ; Makker SP
    J Am Soc Nephrol; 1990 Nov; 1(5):792-8. PubMed ID: 2133428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330.
    Pietromonaco S; Kerjaschki D; Binder S; Ullrich R; Farquhar MG
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1811-5. PubMed ID: 2408041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of receptor-associated 39/45 kD protein in active Heymann nephritis.
    Huang J; Makker SP
    Kidney Int; 1995 Feb; 47(2):432-41. PubMed ID: 7723231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis.
    Specht Grijp-Glandorf RJ; De Heer E; Dekker-Nooren CC; Daha MR; Van Es LA
    Immunology; 1990 Jul; 70(3):290-5. PubMed ID: 1696240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with mycophenolate mofetil attenuates the development of Heymann nephritis.
    Luca ME; Paul LC; van Der Wal AM; Bruijn JA; de Heer E
    Exp Nephrol; 2000; 8(2):77-83. PubMed ID: 10729746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephritogenicity and immunocytochemical localization of the 70-kilodalton glycoprotein subunit (gp70) of Heymann antigen.
    Singh AK; Schwartz MM
    Clin Immunol Immunopathol; 1988 Jul; 48(1):61-77. PubMed ID: 3289803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel autoantibody to plasminogen and its characterization in Heymann nephritis.
    Makker SP
    Clin Immunol Immunopathol; 1994 Jul; 72(1):105-13. PubMed ID: 8020183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of two forms of GP330. Their role in Heymann nephritis.
    Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
    Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat.
    Adler S; Baker P; Pritzl P; Couser WG
    J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
    Natori Y; Hayakawa I; Shibata S
    Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the nephritogenic autoantibody of Heymann's nephritis on plasminogen-binding to gp330 and activation by urokinase.
    Kanalas JJ
    Biochim Biophys Acta; 1993 Nov; 1225(1):101-6. PubMed ID: 8241286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
    Tsukada Y; Ono K; Maezawa A; Yano S; Naruse T
    Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.